BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuroiwa-Trzmielina J, de Conti A, Scolastici C, Pereira D, Horst MA, Purgatto E, Ong TP, Moreno FS. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. Int J Cancer. 2009;124:2520-2527. [PMID: 19195022 DOI: 10.1002/ijc.24212] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ortega JF, Heidor R, Auriemo AP, Affonso JM, D'Amico T, Herz C, de Conti A, Ract J, Gioieli LA, Purgatto E, Lamy E, Pogribny I, Moreno FS. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis. Carcinogenesis 2021:bgab039. [PMID: 33999989 DOI: 10.1093/carcin/bgab039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mirzaei R, Afaghi A, Babakhani S, Sohrabi MR, Hosseini-Fard SR, Babolhavaeji K, Khani Ali Akbari S, Yousefimashouf R, Karampoor S. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. Biomed Pharmacother 2021;139:111619. [PMID: 33906079 DOI: 10.1016/j.biopha.2021.111619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 30] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vrzáčková N, Ruml T, Zelenka J. Postbiotics, Metabolic Signaling, and Cancer. Molecules 2021;26:1528. [PMID: 33799580 DOI: 10.3390/molecules26061528] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Fan W, Zhang L, Jiang Q, Song W, Yan F, Zhang L. Histone deacetylase inhibitor based prodrugs. Eur J Med Chem 2020;203:112628. [PMID: 32679451 DOI: 10.1016/j.ejmech.2020.112628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
5 Petracci I, Gabbianelli R, Bordoni L. The Role of Nutri(epi)genomics in Achieving the Body's Full Potential in Physical Activity. Antioxidants (Basel) 2020;9:E498. [PMID: 32517297 DOI: 10.3390/antiox9060498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Andrade FO, Furtado KS, Heidor R, Sandri S, Hebeda CB, Miranda MLP, Fernandes LHG, Yamamoto RC, Horst MA, Farsky SHP, Moreno FS. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. Carcinogenesis 2019;40:979-88. [PMID: 30590392 DOI: 10.1093/carcin/bgy190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hou Y, Hou Y, Yao L, Chen S, Fan J, Qian L. Effects of chromium yeast, tributyrin and bile acid on growth performance, digestion and metabolism of Channa argus. Aquac Res 2019;50:836-46. [DOI: 10.1111/are.13954] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zhou L, Mao S, Huang Q, He X, Lin J. Inhibition of anaerobic probiotics on colorectal cancer cells using intestinal microfluidic systems. Sci China Chem 2018;61:1034-42. [DOI: 10.1007/s11426-018-9243-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ortega JF, de Conti A, Tryndyak V, Furtado KS, Heidor R, Horst MA, Fernandes LH, Tavares PE, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget 2016;7:24339-47. [PMID: 27013579 DOI: 10.18632/oncotarget.8248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
10 Nguyen TD, Prykhodko O, Fåk Hållenius F, Nyman M. Effects of monobutyrin and tributyrin on liver lipid profile, caecal microbiota composition and SCFA in high-fat diet-fed rats. J Nutr Sci 2017;6:e51. [PMID: 29152255 DOI: 10.1017/jns.2017.54] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kindrat I, Tryndyak V, de Conti A, Shpyleva S, Mudalige TK, Kobets T, Erstenyuk AM, Beland FA, Pogribny IP. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis. Oncotarget 2016;7:1276-87. [PMID: 26657500 DOI: 10.18632/oncotarget.6004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
12 Manal M, Chandrasekar M, Gomathi Priya J, Nanjan M. Inhibitors of histone deacetylase as antitumor agents: A critical review. Bioorganic Chemistry 2016;67:18-42. [DOI: 10.1016/j.bioorg.2016.05.005] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 20.7] [Reference Citation Analysis]
13 Moreno FS, Heidor R, Pogribny IP. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and Cancer 2016;68:719-33. [DOI: 10.1080/01635581.2016.1180410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
14 Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Dev Res 2016;77:53-72. [PMID: 26899191 DOI: 10.1002/ddr.21295] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
15 Heidor R, de Conti A, Ortega JF, Furtado KS, Silva RC, Tavares PE, Purgatto E, Ract JN, de Paiva SA, Gioielli LA, Pogribny IP, Moreno FS. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis. Mol Nutr Food Res 2016;60:420-9. [PMID: 26548572 DOI: 10.1002/mnfr.201500643] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
16 He J, Dong L, Xu W, Bai K, Lu C, Wu Y, Huang Q, Zhang L, Wang T. Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth Retardation. PLoS One 2015;10:e0136848. [PMID: 26317832 DOI: 10.1371/journal.pone.0136848] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
17 Kusaczuk M, Krętowski R, Bartoszewicz M, Cechowska-Pasko M. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line. Tumour Biol 2016;37:931-42. [PMID: 26260271 DOI: 10.1007/s13277-015-3781-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
18 Hwang GL, van den Bosch MA, Kim YI, Katzenberg R, Willmann JK, Paulmurugan R, Gambhir SS, Hofmann L. Development of a High-Throughput Molecular Imaging-Based Orthotopic Hepatocellular Carcinoma Model. Cureus 2015;7:e281. [PMID: 26180705 DOI: 10.7759/cureus.281] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Steliou K, Faller DV, Pinkert CA, Irwin MH, Moos WH. Bioprotective Carnitinoids: Lipoic Acid, Butyrate, and Mitochondria-Targeting to Treat Radiation Injury: Mitochondrial Drugs Come of Age: BIOPROTECTIVE CARNITINOIDS. Drug Dev Res 2015;76:167-75. [DOI: 10.1002/ddr.21258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Choudhari SK, Cerrone F, Woods T, Joyce K, Flaherty VO, Connor KO, Babu R. Pervaporation separation of butyric acid from aqueous and anaerobic digestion (AD) solutions using PEBA based composite membranes. Journal of Industrial and Engineering Chemistry 2015;23:163-70. [DOI: 10.1016/j.jiec.2014.08.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
21 Anestopoulos I, Voulgaridou GP, Georgakilas AG, Franco R, Pappa A, Panayiotidis MI. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacol Ther. 2015;145:103-119. [PMID: 25205159 DOI: 10.1016/j.pharmthera.2014.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
22 Zhou ZK, Bu DD, Su Z, Jiang YM. Butyrate decreases risk of colonic cancer: Potential mechanisms. Shijie Huaren Xiaohua Zazhi 2014; 22(18): 2539-2546 [DOI: 10.11569/wcjd.v22.i18.2539] [Reference Citation Analysis]
23 Plotnikoff GA. Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment. Glob Adv Health Med. 2014;3:33-43. [PMID: 24891992 DOI: 10.7453/gahmj.2014.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
24 Heidor R, Furtado KS, Ortega JF, de Oliveira TF, Tavares PE, Vieira A, Miranda ML, Purgatto E, Moreno FS. The chemopreventive activity of the histone deacetylase inhibitor tributyrin in colon carcinogenesis involves the induction of apoptosis and reduction of DNA damage. Toxicol Appl Pharmacol 2014;276:129-35. [PMID: 24576724 DOI: 10.1016/j.taap.2014.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
25 Guariento AH, Furtado KS, de Conti A, Campos A, Purgatto E, Carrilho J, Shinohara EM, Tryndyak V, Han T, Fuscoe JC. Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis. Int J Cancer. 2014;135:7-18. [PMID: 24302446 DOI: 10.1002/ijc.28642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
26 Scolastici C, de Conti A, Cardozo MT, Ong TP, Purgatto E, Horst MA, Heidor R, Furtado KS, Bassoli BK, Moreno FS. β-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis: TGF-α, NF-κB, and p53 as cellular targets. Nutr Cancer 2014;66:234-41. [PMID: 24364727 DOI: 10.1080/01635581.2014.863364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Molina S, Moran-valero M, Martin D, Vázquez L, Vargas T, Torres C, Ramirez de Molina A, Reglero G. Antiproliferative effect of alkylglycerols as vehicles of butyric acid on colon cancer cells. Chemistry and Physics of Lipids 2013;175-176:50-6. [DOI: 10.1016/j.chemphyslip.2013.07.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
28 de Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis 2013;34:1900-6. [PMID: 23568954 DOI: 10.1093/carcin/bgt124] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
29 Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV. Butyrate histone deacetylase inhibitors. Biores Open Access 2012;1:192-8. [PMID: 23514803 DOI: 10.1089/biores.2012.0223] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 9.2] [Reference Citation Analysis]
30 de Conti A, Kuroiwa-trzmielina J, Horst MA, Bassoli BK, Chagas CE, Purgatto E, Cavalher FP, Camargo AA, Jordão AA, Vannucchi H, Scolastici C, Ong TP, Moreno FS. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis. The Journal of Nutritional Biochemistry 2012;23:860-6. [DOI: 10.1016/j.jnutbio.2011.04.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
31 Wu J, Zhou Z, Hu Y, Dong S. Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J Genet Genomics 2012;39:375-84. [PMID: 22884094 DOI: 10.1016/j.jgg.2012.05.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
32 Andrade FO, Nagamine MK, Conti AD, Chaible LM, Fontelles CC, Jordão Junior AA, Vannucchi H, Dagli ML, Bassoli BK, Moreno FS, Ong TP. Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells. Braz J Med Biol Res 2012;45:841-50. [PMID: 22714808 DOI: 10.1590/s0100-879x2012007500103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
33 Fung KYC, Cosgrove L, Lockett T, Head R, Topping DL. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 2012;108:820-31. [DOI: 10.1017/s0007114512001948] [Cited by in Crossref: 180] [Cited by in F6Publishing: 178] [Article Influence: 18.0] [Reference Citation Analysis]
34 Li S, Yu X, Guo Y, Kong L. Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy. Cell Microbiol 2012;14:994-1002. [PMID: 22329740 DOI: 10.1111/j.1462-5822.2012.01773.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
35 Ong TP, Moreno FS, Ross SA. Targeting the epigenome with bioactive food components for cancer prevention. J Nutrigenet Nutrigenomics 2011;4:275-92. [PMID: 22353664 DOI: 10.1159/000334585] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
36 Cardozo MT, de Conti A, Ong TP, Scolastici C, Purgatto E, Horst MA, Bassoli BK, Moreno FS. Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J Nutr Biochem 2011;22:130-5. [PMID: 20435455 DOI: 10.1016/j.jnutbio.2009.12.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
37 Rajendran P, Williams DE, Ho E, Dashwood RH. Metabolism as a key to histone deacetylase inhibition. Crit Rev Biochem Mol Biol 2011;46:181-99. [PMID: 21599534 DOI: 10.3109/10409238.2011.557713] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
38 Martín D, Morán-valero MI, Señoráns FJ, Reglero G, Torres CF. In Vitro Intestinal Bioaccessibility of Alkylglycerols Versus Triacylglycerols as Vehicles of Butyric Acid. Lipids 2011;46:277-85. [DOI: 10.1007/s11745-010-3520-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
39 Castello G, Costantini S, Scala S. Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment. J Transl Med 2010;8:109. [PMID: 21047421 DOI: 10.1186/1479-5876-8-109] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
40 Choi SW, Friso S. Epigenetics: A New Bridge between Nutrition and Health. Adv Nutr 2010;1:8-16. [PMID: 22043447 DOI: 10.3945/an.110.1004] [Cited by in Crossref: 360] [Cited by in F6Publishing: 274] [Article Influence: 30.0] [Reference Citation Analysis]
41 Kim GW, Gocevski G, Wu CJ, Yang XJ. Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery. Int J Cell Biol 2010;2010:632739. [PMID: 20976254 DOI: 10.1155/2010/632739] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
42 Wu D, Chen H, Jiang L, Cai J, Xu Z, Cen P. Efficient Separation of Butyric Acid by an Aqueous Two-phase System with Calcium Chloride. Chinese Journal of Chemical Engineering 2010;18:533-7. [DOI: 10.1016/s1004-9541(10)60255-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]